Jupiter Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-75,425
Closed -$1.23M 602
2022
Q1
$1.23M Buy
75,425
+60,625
+410% +$1.55M 0.01% 398
2021
Q4
$707K Buy
14,800
+7,100
+92% +$426K 0.01% 438
2021
Q3
$556K Buy
+7,700
New +$557K 0.01% 463

Other funds holding NBP

Jupiter Asset Management's NBP Position: Q2 2022 in Review

Jupiter Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 75,425 shares — an estimated $1.23M sold.

Jupiter Asset Management first reported a position in NBP in Q3 2021 and held it in 3 quarters. The position peaked at $1.23M in Q1 2022. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Jupiter Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Jupiter Asset Management sold 75,425 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $1.23M.
  • Jupiter Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Jupiter Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $1.23M in Q1 2022.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Jupiter Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.